British multinational pharmaceutical and biotechnology company
In the news · 8
Highlights Late-stage pharmaceutical pipelines from major FTSE players are generating significant clinical data and regulatory milestones that support long-term growth narratives AstraZeneca (LSE:AZN) and GSK (LSE:GSK) are investing heavily in precision medicine and biologics, po…
Highlights AstraZeneca (LSE:AZN) and GSK (LSE:GSK) provide relevant listed-company reference points for this market theme. Healthcare investors are balancing defensive earnings characteristics with pipeline execution, product concentration and research spending. Earnings quality,…
Highlights AstraZeneca (LSE:AZN) and GSK (LSE:GSK) are attracting attention as investors evaluate pipeline execution, launches and research productivity. Healthcare investors are balancing defensive earnings characteristics with pipeline execution, product concentration and resea…
Highlights GSK (LSE:GSK) and AstraZeneca (LSE:AZN) provide relevant listed-company reference points for this market theme. The UK government highlighted more than 6 billion of new AI-related investment and around 8,000 prospective jobs announced around London Tech Week, supportin…
Highlights GSK (LSE:GSK) and AstraZeneca (LSE:AZN) provide relevant listed-company reference points for this market theme. Healthcare investors are balancing defensive earnings characteristics with pipeline execution, product concentration and research spending. Earnings quality,…
Highlights GSK (LSE:GSK) and AstraZeneca (LSE:AZN) provide relevant listed-company reference points for this market theme. Healthcare investors are balancing defensive earnings characteristics with pipeline execution, product concentration and research spending. Earnings quality,…
Highlights GSK (LSE:GSK) and AstraZeneca (LSE:AZN) provide relevant listed-company reference points for this market theme. Banks and investment firms have continued to benefit from strong capital generation, although rate expectations, credit quality and regulation remain importa…
A select group of private companies including Astrazeneca and Jaguar Land Rover will be able to endorse migrants to enter the UK on a skilled talent visa for the first time. The list of over 100 companies, which also includes GSK, Arm and a range of large companies and research s…
More in Healthcare
